Latest Expert Opinions

Signal
Opinion
Expert
COMMENT
COMMENT
July 25, 2018

Disappointing. They contoinue to ramp up their number of beds, but their surgery centres are a wild card. Hang on if you own it. Most of the bad news is behind them, and their number should rise going forward.

Show full opinionHide full opinion

Disappointing. They contoinue to ramp up their number of beds, but their surgery centres are a wild card. Hang on if you own it. Most of the bad news is behind them, and their number should rise going forward.

TOP PICK
TOP PICK
July 25, 2018

Was a past pick. Stock has sold off 52% in the past year, but their growth area is in the U.S. where they just got approval from Georgia. (Analysts' price target: $2.50)

Show full opinionHide full opinion

Was a past pick. Stock has sold off 52% in the past year, but their growth area is in the U.S. where they just got approval from Georgia. (Analysts' price target: $2.50)

COMMENT
COMMENT
July 25, 2018

Earnings yesterday were a lot better than expected. They've had a rough year or so. It looks like they've now dealt with their troubled investments and are starting to re-invest their money. One issue is that the payout ratio is very high, around 98%. They will likely do everything they can to protect its high dividend, over 10%. He's waiting to see what'll happen to the payout ratio.


Show full opinionHide full opinion
Alaris Royalty (AD-T)
July 25, 2018

Earnings yesterday were a lot better than expected. They've had a rough year or so. It looks like they've now dealt with their troubled investments and are starting to re-invest their money. One issue is that the payout ratio is very high, around 98%. They will likely do everything they can to protect its high dividend, over 10%. He's waiting to see what'll happen to the payout ratio.


TOP PICK
TOP PICK
July 25, 2018

A big turnaround story that continues to grow by acquisition. In a competitive space, but they're innovative and they create synergies from their purchases. They've gone from printing to packaging which will grow. (Analysts' price target: $31.94)

Show full opinionHide full opinion

A big turnaround story that continues to grow by acquisition. In a competitive space, but they're innovative and they create synergies from their purchases. They've gone from printing to packaging which will grow. (Analysts' price target: $31.94)

TOP PICK
TOP PICK
July 25, 2018

Two of three divisions are in cannabis--the THC and CBD sides are expanding 5x from their current sizes into 2019. They can't get enough product now, because they're very good at extractions, which boast huge margins. They will have a new facility by year's end, and increase their cash flow give times It's trading at 1x sales. They're great at what they do. (no analysts' price target)


Show full opinionHide full opinion

Two of three divisions are in cannabis--the THC and CBD sides are expanding 5x from their current sizes into 2019. They can't get enough product now, because they're very good at extractions, which boast huge margins. They will have a new facility by year's end, and increase their cash flow give times It's trading at 1x sales. They're great at what they do. (no analysts' price target)


PAST TOP PICK
PAST TOP PICK
July 25, 2018

(A Past Top Pick on July 26, 2017, Down 6%) Hasn't done much and has disappointed. Its UK division is worth much more than the market gives it credit for.

Show full opinionHide full opinion

(A Past Top Pick on July 26, 2017, Down 6%) Hasn't done much and has disappointed. Its UK division is worth much more than the market gives it credit for.